Biotech Startups

Cascade Bio develops enzyme immobilization technology ("Body Armor"), a silica-based coating applied to glass-bead supports that stabilizes enzymes so they last longer and tolerate harsher conditions than other cell-free solutions. Its biocatalysts target chemical manufacturing, including food and pharmaceutical applications.

9 investors

Causaly builds an agentic AI platform for life sciences R&D that retrieves and reasons over scientific evidence, using a scientific knowledge graph and specialized AI agents to support target identification, indication discovery, and regulatory evidence validation. It serves biomedical and pharmaceutical enterprises across the R&D pipeline, from early research through clinical development and post-market.

9 investors

Change Foods uses precision fermentation with microbes to produce real dairy proteins, fats, and flavors without cows, then applies traditional cheesemaking techniques to make animal-free cheese that tastes, stretches, and melts like conventional dairy cheese. The company targets consumers seeking sustainable dairy alternatives.

9 investors

Click Therapeutics develops, validates, and commercializes software-based prescription medical treatments, including software-enhanced drug products that combine digital therapeutics with pharmacotherapy. It targets diseases through a platform-based approach applying neuroscience and neuromodulatory mechanisms for patients with unmet medical needs.

9 investors

Clora operates an AI-powered talent marketplace connecting biotech and pharma teams with 15,000+ vetted life sciences consultants across 300+ skillsets for fractional, on-demand engagements. The platform matches companies to experts across the discovery and development lifecycle and handles contracting, onboarding, and payments.

9 investors

Coherence develops neurotechnology systems that measure and modulate brain activity to treat cancer and other neurological diseases. The company uses bioelectronic interfaces and AI to decode the body's neural signals and enable precise, adaptive therapeutic interventions.

9 investors

Cordance Medical develops medical technology focused on diagnosing and treating patients with brain diseases, drawing on expertise from neurosurgery, neuroimaging, and biomedical engineering.

9 investors

Culture Biosciences operates bioreactors as a service for biotech companies, running fermentation experiments and developing manufacturing processes for customers that engineer organisms to produce therapeutics, materials, fuels, and foods. It pairs its bioreactor operations with proprietary automation and software tools that help customers analyze and contextualize their experimental data.

9 investors

Cyrus operates a protein engineering platform that combines AI and Rosetta computational design methods with a biochemistry lab performing large-scale deep mutagenesis scanning, protein stabilization, immunogenicity reduction, and affinity/specificity tuning. It designs and re-engineers biologic therapeutics, working on internal and partnered drug programs including COVID assets and gene therapy candidates.

9 investors

Edison Scientific builds AI agents for scientific research, enabling researchers and industries to accelerate discovery across biology, chemistry, physics, and related domains. The company combines advances in large language models and scientific reasoning to automate experimental design, literature analysis, and scientific workflows.

9 investors

Biotechnology company using multiplex gene editing to develop genetically engineered porcine organs for human transplantation.

9 investors

Elemental Machines provides an IoT platform combining hardware, software, and data science to monitor lab and manufacturing equipment, environments, and workflows in real time. It serves R&D, manufacturing, academia, and government science operations with continuous monitoring, contextual alerts, and GxP/GMP/GLP compliance support.

9 investors

EngageBio develops DNA-based medicines using proprietary non-viral delivery technology to achieve extended therapeutic expression from a single dose with low manufacturing complexity.

9 investors

Evolv Life develops orally-delivered biomimetic peptides that activate the body's own GLP-1 and GIP pathways to support appetite control, weight loss, and metabolic health without prescriptions or stimulants. It markets these consumer tablets as a new category positioned between supplements and drugs, including an oral GLP-1 biomimetic and a peptide for hair.

9 investors

Evommune develops therapies targeting the underlying sources of chronic inflammatory diseases, aiming to provide underserved patient populations with more than symptomatic relief. The company runs discovery and development programs with a focus on immunology.

9 investors

Fore Biotherapeutics is a clinical-stage oncology company developing targeted cancer therapies, including its lead plixorafenib program. It runs clinical trials such as the Forte Trial and offers expanded access programs for patients.

9 investors

Form Bio develops AI-driven software and bioinformatics tools for genetic medicine and genome engineering, enabling faster and safer design of gene therapies, protein engineering, and manufacturing optimization.

9 investors

Formation Bio develops drugs through partnerships with health systems, academic medical centers, and research sites, focusing on clinical trials in dermatology, rheumatology, and cardiometabolic diseases. The company provides trial management infrastructure, monitoring, technology, and enrollment support to accelerate drug development.

9 investors

Freedom Biosciences develops neuropsychiatric therapeutics, focusing on novel treatments for conditions including depression, PTSD, and alcoholism. The company advances drug candidates through clinical development and regulatory pathways, serving patients with mental health and neurological disorders.

9 investors

Genecis Bio converts organic food waste into biodegradable bioplastics using synthetic biology. The company develops sustainable plastic alternatives aimed at reducing environmental impact.

9 investors

Generation Lab offers an at-home epigenetic aging test (SystemAge) that measures 460 biomarkers across 21 organs and systems using DNA methylation, delivering a personalized aging report and action plan for consumers. It uses a needle-free blood collection device and connects users to a network of longevity clinics for follow-up consultations and retesting.

9 investors

Genomines uses biological systems to extract battery-grade nickel from low-grade soils, producing critical metals at lower cost and environmental impact than traditional mining. The company cultivates "metal farms" to create a more sustainable and decentralized supply chain for nickel used in batteries and electronics.

9 investors

Gourmey produces cultivated meat, with its first product being a lab-grown foie gras aimed at fine-dining chefs and restaurants. The company develops sustainable alternatives to conventional meat production for the culinary and food industry.

9 investors

Healx uses artificial intelligence to redevelop, combine, and enhance known compounds to build a pipeline of therapies for rare diseases, with an expanding focus on oncology and preventing cancer recurrence. The company runs multiple drug discovery programmes in parallel, bringing candidate treatments from prediction through clinical trials.

9 investors